ATE550439T1 - Immortalisierte menschlische keratinozytenzell- linie - Google Patents

Immortalisierte menschlische keratinozytenzell- linie

Info

Publication number
ATE550439T1
ATE550439T1 AT06003693T AT06003693T ATE550439T1 AT E550439 T1 ATE550439 T1 AT E550439T1 AT 06003693 T AT06003693 T AT 06003693T AT 06003693 T AT06003693 T AT 06003693T AT E550439 T1 ATE550439 T1 AT E550439T1
Authority
AT
Austria
Prior art keywords
cell line
immortalized human
epidermis
culture
human keratinocyte
Prior art date
Application number
AT06003693T
Other languages
English (en)
Inventor
Lynn Allen-Hoffmann
Michael A Pickart
Sandra J Schlosser
Original Assignee
Wisconsin Alumni Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wisconsin Alumni Res Found filed Critical Wisconsin Alumni Res Found
Application granted granted Critical
Publication of ATE550439T1 publication Critical patent/ATE550439T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0625—Epidermal cells, skin cells; Cells of the oral mucosa
    • C12N5/0629—Keratinocytes; Whole skin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0693—Tumour cells; Cancer cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0697—Artificial constructs associating cells of different lineages, e.g. tissue equivalents
    • C12N5/0698—Skin equivalents
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5014—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/09—Coculture with; Conditioned medium produced by epidermal cells, skin cells, oral mucosa cells
    • C12N2502/094—Coculture with; Conditioned medium produced by epidermal cells, skin cells, oral mucosa cells keratinocytes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/13—Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"
    • C12N2502/1323—Adult fibroblasts
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/30—Coculture with; Conditioned medium produced by tumour cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2503/00—Use of cells in diagnostics
    • C12N2503/02—Drug screening
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2503/00—Use of cells in diagnostics
    • C12N2503/04—Screening or testing on artificial tissues
    • C12N2503/06—Screening or testing on artificial skin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/04—Immortalised cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/10—Screening for compounds of potential therapeutic value involving cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Physics & Mathematics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Food Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT06003693T 1998-07-13 1999-07-12 Immortalisierte menschlische keratinozytenzell- linie ATE550439T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/114,557 US5989837A (en) 1998-07-13 1998-07-13 Immortalized human keratinocyte cell line

Publications (1)

Publication Number Publication Date
ATE550439T1 true ATE550439T1 (de) 2012-04-15

Family

ID=22355986

Family Applications (2)

Application Number Title Priority Date Filing Date
AT99933896T ATE329611T1 (de) 1998-07-13 1999-07-12 Immortalisierte menschliche keratinozytenzell- linie
AT06003693T ATE550439T1 (de) 1998-07-13 1999-07-12 Immortalisierte menschlische keratinozytenzell- linie

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT99933896T ATE329611T1 (de) 1998-07-13 1999-07-12 Immortalisierte menschliche keratinozytenzell- linie

Country Status (15)

Country Link
US (6) US5989837A (de)
EP (2) EP1693066B1 (de)
JP (1) JP3557172B2 (de)
KR (1) KR100461853B1 (de)
CN (1) CN1197960C (de)
AT (2) ATE329611T1 (de)
AU (1) AU758141B2 (de)
BR (1) BRPI9912047B8 (de)
CA (1) CA2336717C (de)
DE (1) DE69931941T2 (de)
DK (1) DK1117423T3 (de)
ES (2) ES2267277T3 (de)
IL (1) IL140608A (de)
NZ (1) NZ509184A (de)
WO (1) WO2000003244A2 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6964869B2 (en) * 1998-07-13 2005-11-15 Wisconsin Alumni Research Foundation Method and composition for skin grafts
US20060030044A1 (en) * 1998-07-13 2006-02-09 Allen-Hoffmann B Lynn Method and composition for skin grafts
US5989837A (en) * 1998-07-13 1999-11-23 Wisconsin Alumni Research Foundation Immortalized human keratinocyte cell line
NZ528166A (en) * 2001-03-02 2007-05-31 Stratatech Corp A method for preparing a seeded dermal equivalent
US6974697B2 (en) * 2001-03-02 2005-12-13 Stratech Corporation Skin substitutes with improved barrier function
IL158526A0 (en) * 2001-04-24 2004-05-12 Wisconsin Alumni Res Found Method and composition for skin grafts
NZ536205A (en) * 2002-04-30 2008-04-30 Stratatech Corp Keratinocytes expressing exogenous angiogenic growth factors
US20030219416A1 (en) * 2002-05-24 2003-11-27 Marcia Simon Long-lived keratinocytes
US7462448B2 (en) * 2002-08-02 2008-12-09 Stratatech Corporation Species specific DNA detection
US9453251B2 (en) 2002-10-08 2016-09-27 Pfenex Inc. Expression of mammalian proteins in Pseudomonas fluorescens
FR2847268B1 (fr) * 2002-11-19 2006-09-29 Coletica Procede d'identification d'une modification eventuelle d'au moins un parametre biologique mettant en oeuvre des cellules vivantes soumises a un stress et des cellules vivantes non soumises a ce meme stress
FR2847269B1 (fr) * 2002-11-19 2006-07-28 Coletica Procede d'identification d'une modification eventuelle d'au moins un parametre biologique mettant en oeuvre des cellules vivantes jeunes et agees
US20040191842A1 (en) * 2002-12-10 2004-09-30 Medical College Of Georgia Research Institute, Inc. Chemopreventive and therapeutic aspects of polyphenolic compositions and assays
US20070105824A1 (en) * 2003-04-29 2007-05-10 Erickson-Miller Connie L Methods for treating degenerative diseases/injuries
EP2481287B1 (de) 2003-08-01 2016-07-20 Stratatech Corporation Exogene Polypeptide exprimierende Äquivalente menschlicher Haut
JP2008507294A (ja) 2004-07-26 2008-03-13 ダウ グローバル テクノロジーズ インコーポレイティド 菌株遺伝子操作による改善されたタンパク質発現のための方法
US9163076B2 (en) * 2005-03-01 2015-10-20 Stratatech Corporation Human skin equivalents expressing exogenous polypeptides
WO2006101834A1 (en) 2005-03-17 2006-09-28 Stratatech Corporation Skin substitutes with improved purity
WO2007035213A2 (en) 2005-08-09 2007-03-29 Revivicor, Inc. Transgenic ungulates expressing ctla4-ig and uses thereof
EP2142651B1 (de) 2007-04-27 2013-05-22 Pfenex Inc. Schnellscreeningverfahren für bakterienwirte zur identifizierung bestimmter stämme mit verbessertem ertrag und/oder verbesserter qualität bei der expression heterologer proteine
US9580719B2 (en) 2007-04-27 2017-02-28 Pfenex, Inc. Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins
JP2011510908A (ja) * 2007-06-11 2011-04-07 シャネル パフュームズ ビューテ 皮膚の老化を抑制するためのｆｎ３ｋおよび／またはｆｎ３ｋｒｐの発現を刺激するための有効薬剤の使用
AU2008322567B2 (en) 2007-11-14 2013-01-17 Stratatech Corporation Cold storage of organotypically cultured skin equivalents for clinical applications
CA2742595C (en) 2008-11-04 2014-04-01 Stratatech Corporation Dried and irradiated skin equivalents for ready use
WO2010065907A2 (en) * 2008-12-05 2010-06-10 The United States Of America As Represented By The Secretary, Department Of Health And Human Services Use of a rock inhibitor to sustain primary human keratinocytes in a proliferative state
WO2010135655A2 (en) * 2009-05-21 2010-11-25 Stratatech Corporation Human skin substitutes expressing il-12
KR101055320B1 (ko) 2009-11-25 2011-08-08 서울대학교산학협력단 자발적으로 불멸화 또는 종양화가 유도된 신규 세포주 및 이의 용도
PT3470018T (pt) 2013-03-13 2021-10-04 Stratatech Corp Criopreservação de substitutos de pele humana viáveis
WO2014179559A1 (en) 2013-05-03 2014-11-06 The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. Skin substitutes and methods for hair follicle neogenesis
EP4257158A1 (de) * 2022-04-06 2023-10-11 Servicio Andaluz de Salud Biomimetisches modell von nicht-melanom-hautkrebs und dessen verwendungen

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2663907A (en) * 1949-02-14 1953-12-29 British Celanese Converting fibrous cellulose into an easily powderable form
US2636879A (en) * 1950-04-27 1953-04-28 Du Pont Manufacture of cellulose ethers
US4455237A (en) * 1982-01-05 1984-06-19 James River Corporation High bulk pulp, filter media utilizing such pulp, related processes
DE3833045A1 (de) * 1988-09-29 1990-04-05 Henkel Kgaa Bohrspueladditive auf basis eines polymergemiches, deren verwendung sowie verfahren zur herstellung derselben
US5491084A (en) * 1993-09-10 1996-02-13 The Trustees Of Columbia University In The City Of New York Uses of green-fluorescent protein
DE19632865A1 (de) * 1996-08-14 1998-02-19 Giesecke & Devrient Gmbh Verfahren zur Herstellung von Papiermasse
US6174412B1 (en) * 1998-03-02 2001-01-16 Purely Cotton, Inc. Cotton linter tissue products and method for preparing same
US5989837A (en) * 1998-07-13 1999-11-23 Wisconsin Alumni Research Foundation Immortalized human keratinocyte cell line
JP4195289B2 (ja) * 2000-11-01 2008-12-10 ビーケイアイ・ホールディング・コーポレーション セルロースエーテル及びその製造方法

Also Published As

Publication number Publication date
ATE329611T1 (de) 2006-07-15
ES2267277T3 (es) 2007-03-01
NZ509184A (en) 2003-01-31
BRPI9912047A (pt) 2001-04-03
CN1326354A (zh) 2001-12-12
EP1117423B1 (de) 2006-06-14
US5989837A (en) 1999-11-23
DK1117423T3 (da) 2006-10-16
US6514711B2 (en) 2003-02-04
WO2000003244A3 (en) 2001-04-26
EP1117423A2 (de) 2001-07-25
KR20010071839A (ko) 2001-07-31
IL140608A (en) 2006-06-11
JP2002520594A (ja) 2002-07-09
US20010023061A1 (en) 2001-09-20
BRPI9912047B1 (pt) 2014-03-18
AU758141B2 (en) 2003-03-13
US6485724B2 (en) 2002-11-26
EP1693066A2 (de) 2006-08-23
WO2000003244A9 (en) 2000-03-23
EP1693066B1 (de) 2012-03-21
JP3557172B2 (ja) 2004-08-25
KR100461853B1 (ko) 2004-12-14
EP1693066A3 (de) 2007-11-21
DE69931941D1 (de) 2006-07-27
AU4985099A (en) 2000-02-01
CA2336717C (en) 2012-05-22
CA2336717A1 (en) 2000-01-20
CN1197960C (zh) 2005-04-20
US20040265787A9 (en) 2004-12-30
WO2000003244A2 (en) 2000-01-20
US20020142282A1 (en) 2002-10-03
US20020102726A1 (en) 2002-08-01
US6884595B2 (en) 2005-04-26
IL140608A0 (en) 2002-02-10
US20030157476A1 (en) 2003-08-21
US6495135B2 (en) 2002-12-17
ES2384264T3 (es) 2012-07-03
DE69931941T2 (de) 2007-02-08
BRPI9912047B8 (pt) 2021-07-06
US6214567B1 (en) 2001-04-10

Similar Documents

Publication Publication Date Title
ATE550439T1 (de) Immortalisierte menschlische keratinozytenzell- linie
AU2569599A (en) Cells or tissues with increased protein factors and methods of making and using same
EP0845963A4 (de) Gebrauch von autologen, dermalen fibroblasten zur reperatur von haut- oder weichgewebeschäden
TR199500882A2 (tr) Biyolojik sun'i organlar icindeki kapali kalan hücrelerin büyüme kontrol yöntemleri ve icerikleri.
DE69737684D1 (de) Präzise wirksamkeitsbestimmungsmethode für wirkstoffe einschliesslich chemotherapeutika
PT789074E (pt) Equivalente de pele compreendendo celulas de langerhans
PL327320A1 (en) Improved immortalised cell lines of human skin and novel serum-free culture medium useful in obtaining them
ATE255420T1 (de) Verwendung von tumorzellen zeitversetzt in kombination mit intakten antikörpern zur immunisierung
NO20006096D0 (no) Medium for dyrking av dyreceller og fremgangsmåte for fremstilling av protein ved anvendelse av det samme
BR9703386A (pt) Células aviárias imortalizadas
ATE384079T1 (de) Marker für stammzellen und dessen verwendung
EG22153A (en) Method for joining marking and structurally modifying monofilaments
CY1106955T1 (el) Μεθοδος για συνθεση για δερματικα μοσχευματα
NO972277D0 (no) Framgangsmåte og celle for framstilling av variant-nisin
DK0851028T3 (da) Immortaliseret human hornhindeepitalcellelinje
Wischermann et al. Improved alkaline comet assay protocol for adherent HaCaT keratinocytes to study UVA-induced DNA damage
ATE289349T1 (de) Vorläufer von normalen neuralen epithelzellen
HUP0101936A3 (en) Biogenic control and limitation of the reproduction of parasitic earth nematodes in stock culture
DE59813481D1 (de) Träger für Zellkulturen
ATE408003T1 (de) Medium zur züchtung von tumorzellen
ATE285076T1 (de) Verwendung von molt4 cd69 expression zur bestimmung der anwesenheit und der aktivität von interferoninhibitoren
DE60328770D1 (de) Ein neuer biologischer tumormarker und methoden für die detektion des krebsartigen oder nicht krebsartigen phenotyps von zellen
UA49472A (uk) Спосіб прогнозування ускладнень при гострому деструктивному апендициті